- Home
- ATHA vs WKSP Comparison
ATHA vs WKSP Comparison
Compare ATHA & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- WKSP
- Stock Information
- Founded
- ATHA 2011
- WKSP 2003
- Country
- ATHA United States
- WKSP United States
- Employees
- ATHA N/A
- WKSP N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- WKSP Auto Parts:O.E.M.
- Sector
- ATHA Health Care
- WKSP Consumer Discretionary
- Exchange
- ATHA Nasdaq
- WKSP Nasdaq
- Market Cap
- ATHA 14.8M
- WKSP 14.6M
- IPO Year
- ATHA 2020
- WKSP N/A
- Fundamental
- Price
- ATHA $0.36
- WKSP $3.53
- Analyst Decision
- ATHA Hold
- WKSP Strong Buy
- Analyst Count
- ATHA 3
- WKSP 3
- Target Price
- ATHA $0.50
- WKSP $12.83
- AVG Volume (30 Days)
- ATHA 149.8K
- WKSP 548.2K
- Earning Date
- ATHA 11-06-2025
- WKSP 08-13-2025
- Dividend Yield
- ATHA N/A
- WKSP N/A
- EPS Growth
- ATHA N/A
- WKSP N/A
- EPS
- ATHA N/A
- WKSP N/A
- Revenue
- ATHA N/A
- WKSP $12,395,166.00
- Revenue This Year
- ATHA N/A
- WKSP $163.94
- Revenue Next Year
- ATHA N/A
- WKSP $78.39
- P/E Ratio
- ATHA N/A
- WKSP N/A
- Revenue Growth
- ATHA N/A
- WKSP 232.13
- 52 Week Low
- ATHA $0.22
- WKSP $2.44
- 52 Week High
- ATHA $0.83
- WKSP $12.00
- Technical
- Relative Strength Index (RSI)
- ATHA 36.59
- WKSP 53.78
- Support Level
- ATHA $0.35
- WKSP $3.29
- Resistance Level
- ATHA $0.40
- WKSP $3.79
- Average True Range (ATR)
- ATHA 0.02
- WKSP 0.37
- MACD
- ATHA -0.00
- WKSP 0.04
- Stochastic Oscillator
- ATHA 11.86
- WKSP 44.20
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.